Video

Affordable Care and Specialty Pharmacy

Author(s):

Davy James, Managing Editor

David Lassen, chief clinical officer at Prime Therapeutics, discusses implications for specialty pharmacy from health care reform.

David Lassen, chief clinical officer at Prime Therapeutics, discusses implications for specialty pharmacy from health care reform.

Related Videos
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Related Content
Investigational semaglutide dosage reduces weight loss by 20.7%. | Image Credit: alones | stock.adobe.com
January 23rd 2025

Investigational Dose of Semaglutide Shows 20.7% Weight Loss at 72 Weeks

Ashley Gallagher, Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

IV drip -- Image credit: sudok1 | stock.adobe.com
January 22nd 2025

Cost Avoidance and Satisfaction Associated With Clinical Pharmacy Services in a Veterans Affairs Specialty Clinic

Miranda Beaudoin Rampone, PharmD, MSCS, CSP Bryce A. Edwards, PharmD, RPh Allison Spaulding, PharmD Leslie Ochs, PharmD, PhD, BCPS
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Genetic Hemophilia Testing: Blood Sample Analysis for Inherited Condition
January 21st 2025

Proper Dosing, Bleeding Awareness Essential Roles of Pharmacists for Hemophila A and B, Thombocytopenic Purpura Treatment

Luke Halpern, Assistant Editor
GLP-1, Diabetes, Type 2 Diabetes | Image Credit: © neirfy | stock.adobe.com
January 20th 2025

ASHP Midyear: Expert Discusses GLP-1 Medications and Incretin Mimetics for Diabetes Care

Ashley Gallagher, Editor